If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer

Non-small-cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) mutations has notoriously challenged oncologists and researchers for three notable reasons: (1) the historical assumption that KRAS is “undruggable”, (2) the disease heterogeneity and (3) the shaping of the tumor microenvironment by...

Descripción completa

Detalles Bibliográficos
Autores principales: Köhler, Jens, Jänne, Pasi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002337/
https://www.ncbi.nlm.nih.gov/pubmed/33809660
http://dx.doi.org/10.3390/ijms22063025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002337/
https://www.ncbi.nlm.nih.gov/pubmed/33809660
http://dx.doi.org/10.3390/ijms22063025

Ejemplares similares